A Double-Blind, Randomized, Two Arm Phase 2 Study Of Nivolumab In Combination With Ipilimumab Versus Nivolumab In Combination With Ipilimumab Placebo
Posted Date: May 15, 2019
- Investigator: Trisha Wise-Draper
- Type of Study: Drug
The purpose of this study is to compare how well the study drugs works, safety, and tolerability of the combination of two study drugs called nivolumab and ipilimumab in subjects with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).
Criteria:
To Be Eligible To Participate In This Study, Patients Must Have Recurrent Or Metastatic Squamous Cel
Keywords:
Ca209-714, Cancer, Head & Neck, Phase 2
For More Information:
Uc Cancer Center
(513) 584-7698
kastla@ucmail.uc.edu